Search Results

There are 6421 results for: content related to: Cost–utility analysis of oral deferasirox versus infusional deferoxamine in transfusion-dependent β-thalassemia patients

  1. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia


    Volume 54, Issue 6, June 2014, Pages: 1542–1551, June-Won Cheong, Hyeoung-Joon Kim, Kyoo-Hyung Lee, Sung-Soo Yoon, Jae Hoon Lee, Hee-Sook Park, Ho Young Kim, Hyeok Shim, Chu-Myung Seong, Chul Soo Kim, Jooseop Chung, Myung Soo Hyun, Deog-Yeon Jo, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, Byung Soo Kim, Young-Don Joo, Chi-Young Park, Yoo Hong Min and for the Korean Society of Hematology Acute Myeloid Leukemia/Myelodysplastic Syndrome Working Party

    Article first published online : 3 DEC 2013, DOI: 10.1111/trf.12507

  2. Combination therapy of deferasirox and deferoxamine shows significant improvements in markers of iron overload in a patient with β-thalassemia major and severe iron burden


    Volume 54, Issue 3, March 2014, Pages: 646–649, Ersi Voskaridou, Veroniki Komninaka, Antonis Karavas, Evangelos Terpos, Vasilis Akianidis and Dimitrios Christoulas

    Article first published online : 9 JUL 2013, DOI: 10.1111/trf.12335

  3. Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization

    British Journal of Haematology

    Volume 170, Issue 6, September 2015, Pages: 874–883, Evangelia Vlachodimitropoulou Koumoutsea, Maciej Garbowski and John Porter

    Article first published online : 1 JUN 2015, DOI: 10.1111/bjh.13512

  4. Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload


    Volume 55, Issue 7, July 2015, Pages: 1613–1620, Il-Hwan Kim, Joon-Ho Moon, Sung-Nam Lim, Sang-Kyun Sohn, Hoon-Gu Kim, Gyeong-Won Lee, Yang-Soo Kim, Ho-Sup Lee, Ki-Young Kwon, Sung-Hyun Kim, Kyung-Tae Park, Joo-Seop Chung, Won-Sik Lee, Sang-Min Lee, Myung-Soo Hyun, Hawk Kim, Hun-Mo Ryoo, Sung-Hwa Bae and Young-Don Joo

    Article first published online : 11 MAR 2015, DOI: 10.1111/trf.13036

  5. Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload

    European Journal of Haematology

    Volume 88, Issue 5, May 2012, Pages: 431–438, Yesim Aydinok, Sule Unal, Yesim Oymak, Canan Vergin, Zeynep D. Türker, Dilek Yildiz and Akif Yesilipek

    Article first published online : 7 MAR 2012, DOI: 10.1111/j.1600-0609.2012.01769.x

  6. The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells

    British Journal of Haematology

    Volume 170, Issue 2, July 2015, Pages: 236–246, Tiziana Tataranni, Francesca Agriesti, Carmela Mazzoccoli, Vitalba Ruggieri, Rosella Scrima, Ilaria Laurenzana, Fiorella D'Auria, Franca Falzetti, Mauro Di Ianni, Pellegrino Musto, Nazzareno Capitanio and Claudia Piccoli

    Article first published online : 30 MAR 2015, DOI: 10.1111/bjh.13381

  7. Safety of deferasirox: a retrospective cohort study on the risks of gastrointestinal, liver and renal events

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 11, November 2014, Pages: 1176–1182, Weng-Foung Huang, Hsin-Chun Chou, Yi-Wen Tsai and Fei-Yuan Hsiao

    Article first published online : 19 JUN 2014, DOI: 10.1002/pds.3657

  8. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients

    European Journal of Haematology

    Volume 95, Issue 5, November 2015, Pages: 411–420, Mohsen S. Elalfy, Amira M Adly, Yasser Wali, Samir Tony, Ahmad Samir and Yasmine I. Elhenawy

    Article first published online : 27 MAR 2015, DOI: 10.1111/ejh.12507

  9. You have free access to this content
    Current approach to iron chelation in children

    British Journal of Haematology

    Volume 165, Issue 6, June 2014, Pages: 745–755, Yesim Aydinok, Antonis Kattamis and Vip Viprakasit

    Article first published online : 20 MAR 2014, DOI: 10.1111/bjh.12825

  10. Combination therapy – deferasirox and deferoxamine – in thalassemia major patients in emerging countries with limited resources

    Transfusion Medicine

    Volume 25, Issue 1, February 2015, Pages: 8–12, N. Arandi, S. Haghpanah, S. Safaei, Z. Zahedi, A. Ashrafi, P. Eatemadfar, T. Zarei, A. H Radwan, A. T Taher and M. Karimi

    Article first published online : 19 MAR 2015, DOI: 10.1111/tme.12188

  11. Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom


    Diana Weidlich, Panos Kefalas and Julian F. Guest

    Article first published online : 4 APR 2016, DOI: 10.1111/trf.13513

  12. Iron chelation therapy in the management of transfusion-related cardiac iron overload


    Volume 52, Issue 10, October 2012, Pages: 2256–2268, Juliano Lara Fernandes

    Article first published online : 8 MAR 2012, DOI: 10.1111/j.1537-2995.2012.03580.x

  13. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices


    Volume 54, Issue 5, May 2014, Pages: 1418–1437, Ratti Ram Sharma, Kathryn Pollock, Allison Hubel and David McKenna

    Article first published online : 16 OCT 2013, DOI: 10.1111/trf.12421

  14. You have full text access to this OnlineOpen article
    Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation


    Volume 55, Issue 12, December 2015, Pages: 2983–3000, Steve Kleinman and Adonis Stassinopoulos

    Article first published online : 25 AUG 2015, DOI: 10.1111/trf.13259

  15. You have full text access to this OnlineOpen article
    Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit

    European Journal of Haematology

    Volume 85, Issue 4, October 2010, Pages: 335–344, Vassilios Ladis, Giorgos Chouliaras, Vasilios Berdoukas, Panagiotis Moraitis, Kirykos Zannikos, Eleni Berdoussi and Christos Kattamis

    Article first published online : 18 JUN 2010, DOI: 10.1111/j.1600-0609.2010.01491.x

  16. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States


    Volume 54, Issue 3pt2, March 2014, Pages: 889–899, Matthew S. Simon, Jared A. Leff, Ankur Pandya, Melissa Cushing, Beth H. Shaz, David P. Calfee, Bruce R. Schackman and Alvin I. Mushlin

    Article first published online : 19 NOV 2013, DOI: 10.1111/trf.12492

  17. Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates


    Volume 54, Issue 5, May 2014, Pages: 1406–1417, Robert Klamroth, Albrecht Gröner and Toby L. Simon

    Article first published online : 30 SEP 2013, DOI: 10.1111/trf.12423

  18. Current and historical perspectives on methodological flaws in processing umbilical cord blood


    Volume 53, Issue 11, November 2013, Pages: 2667–2674, J.N. Mehrishi

    Article first published online : 22 FEB 2013, DOI: 10.1111/trf.12122

  19. Methodologic quality assessment of red blood cell transfusion guidelines and the evidence base of more restrictive transfusion thresholds


    Volume 56, Issue 2, February 2016, Pages: 472–480, Hans Van Remoortel, Emmy De Buck, Tessa Dieltjens, Nele S. Pauwels, Veerle Compernolle and Philippe Vandekerckhove

    Article first published online : 6 NOV 2015, DOI: 10.1111/trf.13385

  20. You have free access to this content
    Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia

    Intervention Review

    The Cochrane Library

    Sheila A Fisher, Susan J Brunskill, Carolyn Doree, Sarah Gooding, Onima Chowdhury and David J Roberts

    Published Online : 21 AUG 2013, DOI: 10.1002/14651858.CD004450.pub3